CN1016420B - 苯并二氢呋喃羧酰胺衍生物的制备方法 - Google Patents

苯并二氢呋喃羧酰胺衍生物的制备方法

Info

Publication number
CN1016420B
CN1016420B CN87100978A CN87100978A CN1016420B CN 1016420 B CN1016420 B CN 1016420B CN 87100978 A CN87100978 A CN 87100978A CN 87100978 A CN87100978 A CN 87100978A CN 1016420 B CN1016420 B CN 1016420B
Authority
CN
China
Prior art keywords
methyl
dihydrobenzofuranes
carboxylic acid
gram
cyclohexenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CN87100978A
Other languages
English (en)
Chinese (zh)
Other versions
CN87100978A (zh
Inventor
雅克琳·弗朗塞西尼
若塞特·马尔加里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Delagrange SA
Original Assignee
Laboratoires Delagrange SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Delagrange SA filed Critical Laboratoires Delagrange SA
Publication of CN87100978A publication Critical patent/CN87100978A/zh
Priority to CN92100139A priority Critical patent/CN1062144A/zh
Publication of CN1016420B publication Critical patent/CN1016420B/zh
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyamides (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN87100978A 1986-01-30 1987-01-28 苯并二氢呋喃羧酰胺衍生物的制备方法 Expired CN1016420B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN92100139A CN1062144A (zh) 1986-01-30 1992-01-04 苯并二氢吡喃羧酰胺衍生物的制备方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8601279 1986-01-30
FR8601279A FR2593504B1 (fr) 1986-01-30 1986-01-30 Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN92100139A Division CN1062144A (zh) 1986-01-30 1992-01-04 苯并二氢吡喃羧酰胺衍生物的制备方法

Publications (2)

Publication Number Publication Date
CN87100978A CN87100978A (zh) 1987-09-16
CN1016420B true CN1016420B (zh) 1992-04-29

Family

ID=9331629

Family Applications (2)

Application Number Title Priority Date Filing Date
CN87100978A Expired CN1016420B (zh) 1986-01-30 1987-01-28 苯并二氢呋喃羧酰胺衍生物的制备方法
CN92100139A Pending CN1062144A (zh) 1986-01-30 1992-01-04 苯并二氢吡喃羧酰胺衍生物的制备方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN92100139A Pending CN1062144A (zh) 1986-01-30 1992-01-04 苯并二氢吡喃羧酰胺衍生物的制备方法

Country Status (40)

Country Link
US (1) US5006570A (en.html)
EP (1) EP0231139B1 (en.html)
JP (1) JPS62277376A (en.html)
KR (1) KR870007160A (en.html)
CN (2) CN1016420B (en.html)
AT (1) ATE70063T1 (en.html)
AU (1) AU593605B2 (en.html)
BE (1) BE1000164A5 (en.html)
BG (1) BG46600A3 (en.html)
CA (1) CA1300161C (en.html)
CH (1) CH670827A5 (en.html)
CS (2) CS264288B2 (en.html)
DD (1) DD260065A5 (en.html)
DE (2) DE3702005A1 (en.html)
DK (1) DK46987A (en.html)
ES (2) ES2003671A6 (en.html)
FI (1) FI870347A7 (en.html)
FR (1) FR2593504B1 (en.html)
GB (1) GB2187188B (en.html)
GR (2) GR870134B (en.html)
HU (1) HU206107B (en.html)
IE (1) IE870128L (en.html)
IL (1) IL81299A (en.html)
IN (2) IN164389B (en.html)
IS (1) IS1446B6 (en.html)
IT (1) IT1205729B (en.html)
LU (1) LU86747A1 (en.html)
MA (1) MA20861A1 (en.html)
NO (1) NO168582C (en.html)
NZ (1) NZ219068A (en.html)
OA (1) OA08472A (en.html)
PH (1) PH23392A (en.html)
PL (2) PL152404B1 (en.html)
PT (1) PT84224B (en.html)
SU (2) SU1609451A3 (en.html)
TN (1) TNSN87012A1 (en.html)
YU (1) YU46185B (en.html)
ZA (1) ZA87552B (en.html)
ZM (1) ZM987A1 (en.html)
ZW (1) ZW1387A1 (en.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2611715B1 (fr) * 1987-02-27 1989-05-12 Adir Nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2611713B1 (fr) * 1987-02-27 1990-11-30 Adir Nouveaux derives de l'acide (dihydro-2,3 oxo-2 benzofurannyl-3)-2 acetique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
JP2726306B2 (ja) * 1989-04-14 1998-03-11 本田技研工業株式会社 車両の前後輪操舵装置
US5122361A (en) * 1989-04-17 1992-06-16 Trustees Of The University Of Pennsylvania Dopamine receptor ligands and imaging agents
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
GB9005014D0 (en) 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
WO1991017144A1 (en) * 1990-05-02 1991-11-14 Yoshitomi Pharmaceutical Industries, Ltd. Amide compound, pharmaceutical use thereof and novel 1-substituted pyrrolidinemethyl-amines
US5114947A (en) * 1990-12-27 1992-05-19 Erbamont Inc. Method for alleviating anxiety using benzobicyclic carboxamides
MA22647A1 (fr) * 1991-09-14 1993-04-01 Smithkline Beecham Plc Procede de preparation d'un ester ou d'un amide d'un nouveau produit .
NZ246915A (en) * 1992-02-06 1996-05-28 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives, preparation and pharmaceutical compositions thereof
WO1994008994A1 (en) * 1992-10-13 1994-04-28 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists
US6127379A (en) * 1993-02-01 2000-10-03 Smithkline Beecham P.L.C. Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
RU2129556C1 (ru) * 1993-08-19 1999-04-27 Жансен Фармасетика Н.В. Производное дигидробензопирана, обладающее сосудосуживающим действием, промежуточные соединения, способы получения, фармацевтическая композиция и способ ее получения
JP2999669B2 (ja) * 1993-08-24 2000-01-17 株式会社三和化学研究所 ベンゾ［ｂ］フランカルボキサミド誘導体、その製法及び用途
JPH0820586A (ja) * 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
JPH0873463A (ja) 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
TW475930B (en) * 1995-04-24 2002-02-11 Novartis Ag Novel compound, its use and pharmaceutical composition comprising it

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135545A1 (en) * 1983-02-19 1985-04-03 Beecham Group Plc Azabicycloalkyl benzamide and anilide derivatives
JPS59186969A (ja) * 1983-04-08 1984-10-23 Yoshitomi Pharmaceut Ind Ltd ベンゾフラン−およびベンゾピランカルボキサミド誘導体
CA1297877C (en) * 1983-12-22 1992-03-24 Daniel Lednicer Benzofurancarboxamides useful as antiemetic or antipsychotic agents
JPS63139180A (ja) * 1986-12-02 1988-06-10 Tanabe Seiyaku Co Ltd カルボン酸誘導体

Also Published As

Publication number Publication date
EP0231139A2 (fr) 1987-08-05
IT1205729B (it) 1989-03-31
DE3702005A1 (de) 1987-08-06
FI870347A7 (fi) 1987-07-31
BG46600A3 (en) 1990-01-15
KR870007160A (ko) 1987-08-17
NO168582B (no) 1991-12-02
GB2187188A (en) 1987-09-03
IL81299A0 (en) 1987-08-31
CA1300161C (fr) 1992-05-05
NO870199D0 (no) 1987-01-16
FR2593504A1 (fr) 1987-07-31
CH670827A5 (en.html) 1989-07-14
PL152491B1 (en) 1990-12-31
TNSN87012A1 (fr) 1990-01-01
GB2187188B (en) 1989-11-08
PT84224B (pt) 1989-03-30
NO168582C (no) 1992-03-11
US5006570A (en) 1991-04-09
PL272298A1 (en) 1989-02-20
DE3774888D1 (de) 1992-01-16
IN164389B (en.html) 1989-03-04
ES2038679T3 (es) 1993-08-01
ZA87552B (en) 1987-10-28
IL81299A (en) 1991-09-16
IE870128L (en) 1987-07-30
ES2003671A6 (es) 1988-11-01
CS264288B2 (en) 1989-06-13
EP0231139A3 (en) 1988-04-27
DK46987D0 (da) 1987-01-29
EP0231139B1 (fr) 1991-12-04
PL263885A1 (en) 1988-09-15
YU11387A (en) 1988-06-30
SU1607688A3 (ru) 1990-11-15
DD260065A5 (de) 1988-09-14
ZW1387A1 (en) 1987-10-28
IS3189A7 (is) 1987-07-31
PT84224A (fr) 1987-02-01
GB8701870D0 (en) 1987-03-04
LU86747A1 (fr) 1987-06-02
FI870347A0 (fi) 1987-01-27
SU1609451A3 (ru) 1990-11-23
CS36288A2 (en) 1988-09-16
NZ219068A (en) 1990-12-21
HUT47093A (en) 1989-01-30
OA08472A (fr) 1988-07-29
CS57887A2 (en) 1988-09-16
JPS62277376A (ja) 1987-12-02
CN87100978A (zh) 1987-09-16
PH23392A (en) 1989-07-26
CS264300B2 (cs) 1989-06-13
AU6785587A (en) 1987-08-06
HU206107B (en) 1992-08-28
YU46185B (sh) 1993-05-28
ATE70063T1 (de) 1991-12-15
ZM987A1 (en) 1987-09-30
CN1062144A (zh) 1992-06-24
GR3003653T3 (en.html) 1993-03-16
FR2593504B1 (fr) 1988-12-09
IN167060B (en.html) 1990-08-25
NO870199L (no) 1987-07-31
AU593605B2 (en) 1990-02-15
MA20861A1 (fr) 1987-10-01
IT8747583A0 (it) 1987-01-29
GR870134B (en) 1987-05-28
BE1000164A5 (fr) 1988-07-05
PL152404B1 (en) 1990-12-31
DK46987A (da) 1987-07-31
IS1446B6 (is) 1990-12-14

Similar Documents

Publication Publication Date Title
CN1016420B (zh) 苯并二氢呋喃羧酰胺衍生物的制备方法
CN1028992C (zh) 1，4，-苯并硫杂吖庚因衍生物的制备方法
CN1117744C (zh) 1－(1,2－双取代哌啶基)－4－取代哌嗪衍生物
CN1078471A (zh) 药品
CN1167764A (zh) 苯并吖嗪衍生物或其盐和含有它们的药物组合物
CN1064964C (zh) 新型苯并二噁烷,它们的制备方法以及含这些化合物的药物组合物
CN1025193C (zh) 抗真菌用的唑酮类衍生物的制备方法
CN1105360A (zh) 1-[2h-1-苯并吡喃-2-酮-8-基]-哌嗪衍生物
CN1768053A (zh) 吡唑化合物
CN1099032A (zh) 苯并噁嗪衍生物，其制备方法及其药用
CN1015627B (zh) 芳香基呱嗪基-亚烷基苯基-杂环化合物的制备方法
EP0673933B1 (fr) Aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CN1101644A (zh) 噻二嗪酮
CN1342148A (zh) 用作因子Xa抑制剂的吡唑－3－酮衍生物
CN1461301A (zh) 苯并[b]噻吩衍生物及其制备方法
CN1145894A (zh) 新的芳基烷基(硫代)甲酰胺，制备此类酰胺的方法和含此类酰胺的药物组合物
CN1232452A (zh) Nmda(n－甲基－d－天冬氨酸)拮抗剂
CN1043700A (zh) 用于治疗尿失禁的化合物
HK1044947B (zh) 苯甲酰胺衍生物及含有它们的药物
CN1128763A (zh) 噁唑并喹啉酮衍生物，它们的制备及其在治疗上的应用
CN1289495C (zh) 新的哌啶基－烷基氨基－哒嗪酮衍生物、其制备方法以及包含所述化合物的药物组合物
CN1990478A (zh) 6－芳基－3－取代亚甲基吡喃酮类化合物及其制备方法和用途
CN1683365A (zh) 取代的二氧戊环衍生物及其用于制备神经调节剂的用途
CN101039930A (zh) 作为结晶硫酸盐的1－[2－(4－甲苯基－4－羟基－哌啶－1－基)－乙基]－3－(2－甲基－喹啉－4－基)－脲
CN1491216A (zh) 用于治疗尿失禁的新颖烷基苯基亚氨咪唑烷衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C13 Decision
GR02 Examined patent application
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee